Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Interferon beta-1a - Biopartners GmbH/Rentschler

Next Previous
Drug Profile

Interferon beta-1a - Biopartners GmbH/Rentschler

Alternative Names: Biferonex; HSA-free IFN β-1a; Human serum albumin-free interferon beta

Latest Information Update: 23 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Rentschler
  • Developer Biopartners GmbH
  • Class Antiasthmatics; Antineoplastics; Antivirals; Interferons; Vascular disorder therapies
  • Mechanism of Action Interferon beta stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Multiple sclerosis

Most Recent Events

  • 30 May 2009 BioPartners withdraws the centralised marketing application for interferon beta-1a for Multiple sclerosis in European Union
  • 19 Feb 2009 The CHMP has issued a negative opinion regarding approval of interferon beta-1a for treatment of Multiple sclerosis in European Union
  • 31 Jul 2007 Preregistration for Multiple sclerosis in European Union (Parenteral)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top